Dealbreaker on MSN13d
Pharmacy Benefit Managers Not Thrilled With FTC Report Finding Pharmacy Benefit Managers Raise Drug PricesThe pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released ...
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...
At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...
Strawberry Hills Pharmacy owner Daniel Jones reacted Thursday to a recent Federal Trade Commission report which showed ...
In the report, the FTC said pharmacy benefit managers (PBMs), charge significant markups for cancer, HIV, and other critical ...
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback